RYLPF (Koninklijke Philips NV) Growth Rank: 4 (As of Jul. 06, 2026) — Near Median


RYLPF Koninklijke Philips NV RYLPF
72 GF Score
Price $28.01
GF Value $25.39
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Koninklijke Philips NV Growth Rank?

Koninklijke Philips NV RYLPF +2.21% 72 Growth Rank is 4 as of Jul. 06, 2026, which is at its 10-year median of 4.00. GuruFocus rates RYLPF with a GF Score™ of 72/100 and a GF Value™ of $25.39 (Fairly Valued). The stock has 5 warning signs investors should review.

Koninklijke Philips NV has the Growth Rank of 4.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Koninklijke Philips NV Growth Rank Related Terms

RYLPF vs ABT, SYK, MDT: Growth Rank Comparison

For the Medical Devices subindustry, Koninklijke Philips NV's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Koninklijke Philips NV Growth Rank vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Koninklijke Philips NV's Growth Rank distribution charts can be found below:

* The bar in red indicates where Koninklijke Philips NV's Growth Rank falls into.


RYLPF
72GF Score
Koninklijke Philips NV RYLPF
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 4 mean?
Koninklijke Philips NV (RYLPF) has a Growth Rank of 4 as of Jul. 06, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Koninklijke Philips NV and its competitors. This is near median its historical median of 4.00. Over the past decade, Koninklijke Philips NV's Growth Rank has ranged from 2.00 to 7.00.
Is Koninklijke Philips NV's Growth Rank too high?
Koninklijke Philips NV's current Growth Rank of 4 is near median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 7.00. Overall, Koninklijke Philips NV has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koninklijke Philips NV's Growth Rank compare to ABT and SYK?
Koninklijke Philips NV's Growth Rank of 4 can be compared against companies in the Medical Devices & Instruments industry. Historically, Koninklijke Philips NV's own Growth Rank has ranged from 2.00 to 7.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Devices & Instruments company?
A good Growth Rank depends on the Medical Devices & Instruments industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Koninklijke Philips NV and its competitors. Koninklijke Philips NV's current Growth Rank is 4, which is near median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koninklijke Philips NV stock overvalued right now?
Based on GuruFocus' analysis, Koninklijke Philips NV (RYLPF) is currently considered Fairly Valued. The stock's GF Value™ is $25.39, compared to a current price of $28.01 — trading 10.3% above its estimated fair value. The current Growth Rank is 4, which is near median its 10-year median of 4.00. Koninklijke Philips NV's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Koninklijke Philips NV (RYLPF), the current Growth Rank is 4 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Koninklijke Philips NV (RYLPF) Overvalued in 2026?

Based on GuruFocus' analysis, Koninklijke Philips NV stock appears to be overvalued. The current stock price of $28.01 is trading 10.3% above its estimated GF Value™ of $25.39. GuruFocus considers Koninklijke Philips NV to be Fairly Valued.

Key valuation signals for RYLPF:

  • Growth Rank: 4 (near median its 10-year median of 4.00)
  • GF Value™: $25.39 vs. price of $28.01 (10.3% above fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the RYLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Koninklijke Philips NV Business Description

Address Prinses Irenestraat 59, Amsterdam, NLD, 1077 WV
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
72GF Score

Get the complete analysis for RYLPF

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.01
Price
$25.39
GF Value